A new ovarian cancer screening test has been developed which involves close examination of the blood. So, in simple terms, it can be said that this new method is a blood test. It can speed up the testing process. This is because it has the potential to detect the development of cancer more quickly. Therefore, it is considered one of the phenomenal advancements in cancer screening.
This new ovarian cancer screening test determines the risk of cancer by analyzing the protein levels in the bloodstream which is linked with cancer. This method interprets the alteration of CA125 protein in the body. The research is led by a professor of gynecologic oncology at University College London, Dr. Usha Menon. She explains this method is based on a few factors, such as the rate of cancer among women of a similar age.
Profiles of women who suffer from ovarian cancer are analyzed closely and the level of CA125 is measured, which gives the researcher the opportunity to further explore the link between the level of CA125 protein and the development of ovarian cancer. The doctors behind the study claim the process previously used for screening was complicated and required unnecessary surgeries, even for a proper diagnosis.
Now, the complications are reduced and the new testing method is working effectively without any of the limitations the doctors previously faced. It is currently available at 13 NHS Trusts. It is believed to be one of the most prominent achievements in the field of cancer treatment in recent years. Research and study is being carried on, which will further enhance the testing procedure. The goal is to detect cancer as soon as the growth of cancerous cells begins. This is because as soon as cancer is diagnosed, the chances of treatment proving effective are greater.
This CA125 tracking is still under development and case studies are being prepared to prove its authenticity and efficiency. Doctors believe it has the potential to be one of the most sensitive and accurate screening methods developed so far.
The team of researchers behind this new ovarian cancer screening is also looking at the profile of the women who are receiving treatment for ovarian cancer. They’re seeing the progress of cells and the difference in the level of protein in the bloodstream. Later, after the analysis of the patient’s reports, the researcher assigns the level of risk and recommends further treatment as these tests will refine the diagnosis and doctors will have a clear view of the patient’s condition.